chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood culture negative, Blood lactic acid, C-reactive protein normal, Cellulitis, Eye swelling
Clinical narrative: Patient had first dose of moderna covid vaccine on April 9th. On 9th and 10th patient had runny nose. Has allergies so patient attributed it to that. 10th evening patient noted nodule on side of nose by inner eye and then began spreading. On 12th, more swollen and painful so patient presented to immediate care visit with swollen area on left nose/cheek-diagnosed as facial cellulitis and started on oral antibiotics clindamycin and augmentin. On 13th, more pain hot - was advised to go to ED but did not wait to be seen. On 14th returned to ED - antibiotics changed to doxycycline and augumentin continued.  Patient woke up with eye swollen shut per md notes. By 4/16 some improvement in swelling noted.
Age: 43.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nodule, Red blood cell sedimentation rate normal, Rhinorrhoea, Skin mass, Skin warm
Clinical narrative: Patient had first dose of moderna covid vaccine on April 9th. On 9th and 10th patient had runny nose. Has allergies so patient attributed it to that. 10th evening patient noted nodule on side of nose by inner eye and then began spreading. On 12th, more swollen and painful so patient presented to immediate care visit with swollen area on left nose/cheek-diagnosed as facial cellulitis and started on oral antibiotics clindamycin and augmentin. On 13th, more pain hot - was advised to go to ED but did not wait to be seen. On 14th returned to ED - antibiotics changed to doxycycline and augumentin continued.  Patient woke up with eye swollen shut per md notes. By 4/16 some improvement in swelling noted.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Palpitations, Tachycardia
Clinical narrative: About 8-10 minutes after first vaccine, I started feeling lightheaded, then my feet started feeling tingly, then I started feeling a little dizzy then my heart accelerated. The accelerated heartbeat lasted no more than 10 seconds.  They pulled me aside and took my blood pressure which was elevated 160/100 (it is usually 110/70).  My pulse was also elevated at 100.   It took about 10-15 minutes to get back to normal.
Age: 57.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood pressure increased, Dizziness, Heart rate increased, Paraesthesia
Clinical narrative: About 8-10 minutes after first vaccine, I started feeling lightheaded, then my feet started feeling tingly, then I started feeling a little dizzy then my heart accelerated. The accelerated heartbeat lasted no more than 10 seconds.  They pulled me aside and took my blood pressure which was elevated 160/100 (it is usually 110/70).  My pulse was also elevated at 100.   It took about 10-15 minutes to get back to normal.
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Death, Fall, Intensive care, Pain
Clinical narrative: 24 hours after vaccination (dose 2) patient felt weak and fell at home. Brough to hospital via EMS on 4/10. No clinical evidence of VITT or CVST. Covid-19 test negative. Diagnosis was chronic a Fib, possible sepsis. Patient was found unresponsive with cPAP not in place. Resuscitation was unsuccessful on 4/13/21. Cause of death: respiratory failure
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain in extremity, Syncope
Clinical narrative: 24 hours after vaccination (dose 2) patient felt weak and fell at home. Brough to hospital via EMS on 4/10. No clinical evidence of VITT or CVST. Covid-19 test negative. Diagnosis was chronic a Fib, possible sepsis. Patient was found unresponsive with cPAP not in place. Resuscitation was unsuccessful on 4/13/21. Cause of death: respiratory failure
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Atrial fibrillation, Condition aggravated, Continuous positive airway pressure, Death
Clinical narrative: 24 hours after vaccination (dose 2) patient felt weak and fell at home. Brough to hospital via EMS on 4/10. No clinical evidence of VITT or CVST. Covid-19 test negative. Diagnosis was chronic a Fib, possible sepsis. Patient was found unresponsive with cPAP not in place. Resuscitation was unsuccessful on 4/13/21. Cause of death: respiratory failure
Age: 80.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Fall, Respiratory failure, Resuscitation, SARS-CoV-2 test negative, Unresponsive to stimuli
Clinical narrative: 24 hours after vaccination (dose 2) patient felt weak and fell at home. Brough to hospital via EMS on 4/10. No clinical evidence of VITT or CVST. Covid-19 test negative. Diagnosis was chronic a Fib, possible sepsis. Patient was found unresponsive with cPAP not in place. Resuscitation was unsuccessful on 4/13/21. Cause of death: respiratory failure
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, Drug ineffective, SARS-CoV-2 test positive
Clinical narrative: A week later got Covid virus, tested positive, mild symptoms but still symptoms; This is a spontaneous report from a non-contactable consumer. A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 03Mar2021 as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 03Mar2021, the patient got first Pfizer vaccine and a week later (Mar2021) she got Covid virus, tested positive with mild symptoms but still symptoms. The patient is due for the second shot on 24Mar2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: A week later got Covid virus, tested positive, mild symptoms but still symptoms; This is a spontaneous report from a non-contactable consumer. A 63-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE) lot number and expiration date not provided, via an unspecified route of administration on 03Mar2021 as single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. On 03Mar2021, the patient got first Pfizer vaccine and a week later (Mar2021) she got Covid virus, tested positive with mild symptoms but still symptoms. The patient is due for the second shot on 24Mar2021. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood magnesium normal, Blood phosphorus normal, Blood potassium normal, Bradycardia
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chest pain, Decreased appetite, Dementia, Dizziness, Dyspnoea
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Electrocardiogram, Electrocardiogram ST segment elevation, Fatigue, Hyperhidrosis, Hypotension
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Malaise, Mental status changes, Mobility decreased, Nausea, Pain
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Presyncope, Pyrexia, SARS-CoV-2 test negative, Troponin increased
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Angiocardiogram, Antinuclear antibody negative, Blood culture negative, C-reactive protein increased, Chest pain
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ejection fraction decreased, Electrocardiogram, Epstein-Barr virus test negative, Magnetic resonance imaging heart, Pericarditis
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 18.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: SARS-CoV-2 test negative, Streptococcus test negative, Troponin increased
Clinical narrative: Patient presented to hospital with severe substernal chest pain with severely elevated troponin and EKG consistent with pericarditis, transferred to a different hospital given worsening cardiac function and rising cardiac enzymes consistent. Inflammatory markers (CRP, non-cardiac) were elevated and infectious workup (strep, COVID-19,  EBV, lyme, blood cultures) were negative. ANA was also negative. Importantly patient was without symptoms prior to COVID-19 vaccination. Cardiac MRI was performed and was consistent with myocarditis with a mildly reduced ejection fraction. Cardiac coronary angiography showed no CAD. Patient was treated with ibuprofen, colchicine and metoprolol (given episodes of NSVT). Patient remained inpatient until 4/21 at which point he was discharged home.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Impaired work ability, Joint swelling
Clinical narrative: I received my first vaccine on 3/17/21 and that was a Pfizer.  When I went for my 2nd vaccine I was administered Moderna.  They had scheduled me on the incorrect day.  They didn't check my information to see which I had the first time.  Since April 9th I have had extreme Joint and Muscle Pain.  I am a very active person and it has knocked me on my rear.  I have been to the Dr. twice and have been put on steroids.   Today was my 2nd time and he has put me on 2 weeks of oral steroids.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Arthralgia, Blood test, Inappropriate schedule of product administration, Myalgia, Wrong product administered
Clinical narrative: I received my first vaccine on 3/17/21 and that was a Pfizer.  When I went for my 2nd vaccine I was administered Moderna.  They had scheduled me on the incorrect day.  They didn't check my information to see which I had the first time.  Since April 9th I have had extreme Joint and Muscle Pain.  I am a very active person and it has knocked me on my rear.  I have been to the Dr. twice and have been put on steroids.   Today was my 2nd time and he has put me on 2 weeks of oral steroids.
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Axillary vein thrombosis, Eosinophil percentage, Haemoglobin normal, Injection site erythema, Injection site warmth
Clinical narrative: right upper extremity partially occlusive subclavian deep venous thrombosis
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphocyte percentage, Metabolic function test normal, Neutrophil percentage, Platelet count normal, Subclavian vein occlusion
Clinical narrative: right upper extremity partially occlusive subclavian deep venous thrombosis
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Subclavian vein thrombosis, Thrombophlebitis superficial, Vaccination site pain, Vaccination site swelling, Venous occlusion
Clinical narrative: right upper extremity partially occlusive subclavian deep venous thrombosis
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: White blood cell count normal
Clinical narrative: right upper extremity partially occlusive subclavian deep venous thrombosis
Age: 56.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Deep vein thrombosis, Ultrasound scan, Ultrasound scan abnormal
Clinical narrative: right upper extremity partially occlusive subclavian deep venous thrombosis
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endotracheal intubation, Extubation, Facetectomy, Intensive care, Magnetic resonance imaging spinal abnormal
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Neck pain, Quadriplegia, Spinal laminectomy
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Activated partial thromboplastin time shortened, Antinuclear antibody negative, Aortic valve calcification, Aortic valve disease, Back pain
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood creatine phosphokinase increased, Blood lactic acid, Computerised tomogram head, Computerised tomogram spine, Echocardiogram abnormal
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Endocarditis, Facetectomy, International normalised ratio increased, Magnetic resonance imaging spinal, Muscle spasms
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Musculoskeletal disorder, Myelitis transverse, Neck pain, Paraesthesia, Prothrombin time prolonged
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Quadriplegia, Red blood cell sedimentation rate normal, SARS-CoV-2 test negative, Spinal cord disorder, Spinal laminectomy
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 65.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Spinal stenosis, Staphylococcal infection, White blood cell count increased
Clinical narrative: 65-year-old man with PMH significant for hypertension, who began to experience neck pain shortly after he had his second dose of the Pfizer COVID-19 vaccine on 4/14/2021. He reports pain started out as aching in his neck and down into his back. His pain got worse and he went to see a chiropractor the next day, where he had massage and neck manipulation which temporarily provided some relief but then the pain worsened. He was seen in ER that night for neck pain and spasms. He was treated with Valium and DC with Rx for Flexeril. He took several doses but pain persisted. This morning, he noticed tingling in bilateral hands, as well as tingling and inability to move his legs. He called EMS and was brought to ED for evaluation. Pt was evaluated by neurologist, was found to be quadriplegic. He was immediately ordered for CT head, CT cervical spine as well as MRI of cervical and thoracic spine. Imaging is notable for enlargement of the spinal cord from the C2 down to C7-T1. Felt to be likely transverse myelitis. Pt also noted to have superimposed cervical spinal stenosis, most significant at C5-6.  The patient was then taken for emergency neurosurgery for a C3-C7 decompressive laminectomy, medial facetectomy on 4/16/2021. Due to lab work findings an infectious workup was completed, patient noted to have MSSA positive blood cultures, and subsequent ECHO demonstrated mild to moderate aortic valve calcification and mobile strands of the aortic cusp.  Treatment was begun for endocarditis.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Feeling drunk, Headache, Herpes zoster, Immediate post-injection reaction
Clinical narrative: Patient developed shingles 2 weeks after first dose
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Nausea, Neuralgia, Pain in extremity, Rash
Clinical narrative: Patient developed shingles 2 weeks after first dose
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Herpes zoster
Clinical narrative: Patient developed shingles 2 weeks after first dose
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Computerised tomogram normal, Laboratory test normal, Magnetic resonance imaging normal, Mental status changes, Transient global amnesia
Clinical narrative: brought in to Nurse treatment Center for sudden onset of confusion.  Per patient she could not remember recent events that transpired early on today.  She states she is at a  facility.  She recognizes husband at the bedside.  She denies dizziness or lightheadedness.  She is not oriented with time and date.  Patient got her second covid vaccine at 11:45 this morning and went to lunch with husband after.  Per husband noticed the sudden onset of confusion at around 12:15 during lunch.  Patient was then brought in the clinic.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Confusional state
Clinical narrative: brought in to Nurse treatment Center for sudden onset of confusion.  Per patient she could not remember recent events that transpired early on today.  She states she is at a  facility.  She recognizes husband at the bedside.  She denies dizziness or lightheadedness.  She is not oriented with time and date.  Patient got her second covid vaccine at 11:45 this morning and went to lunch with husband after.  Per husband noticed the sudden onset of confusion at around 12:15 during lunch.  Patient was then brought in the clinic.
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Fatigue, Pain assessment, Pain in extremity, Thrombosis, Ultrasound scan
Clinical narrative: Pain in right calf DVT diagnosed on Ultrasound
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Fatigue, Gait inability, Muscle spasms, Pain in extremity
Clinical narrative: Pain in right calf DVT diagnosed on Ultrasound
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Thrombosis, Ultrasound Doppler abnormal
Clinical narrative: Pain in right calf DVT diagnosed on Ultrasound
Age: 31.0
Sex: F
Vaccine: COVID19, COVID19, COVID19
Symptoms: Deep vein thrombosis, Pain in extremity, Ultrasound Doppler abnormal
Clinical narrative: Pain in right calf DVT diagnosed on Ultrasound
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Lacrimation increased, Photophobia
Clinical narrative: Left Bell's Palsy.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Bell's palsy, Blood creatinine increased, Blood glucose increased, Carbon dioxide decreased, Full blood count
Clinical narrative: Left Bell's Palsy.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Glycosylated haemoglobin increased, Immunology test, Magnetic resonance imaging head, Metabolic function test, Red blood cell count increased
Clinical narrative: Left Bell's Palsy.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Feeling hot, Headache, Hyperhidrosis, Loss of personal independence in daily activities
Clinical narrative: FEVER; BACKACHE; HEADACHE; STOMACH ACHE; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020) dose was not reported, administered on 04-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021 5 hours post vaccination, the patient experienced fever 100 F, backache, headache, stomach ache, and weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, backache, headache, and stomach ache, and had not recovered from weakness. This report was non-serious.; Sender's Comments: Fever 100 F, backache, headache, stomach ache, and weakness. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship. There are no other factors more likely to be associated with the event(s) than the drug.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Magnetic resonance imaging, Nausea, Pyrexia, Thought blocking
Clinical narrative: FEVER; BACKACHE; HEADACHE; STOMACH ACHE; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020) dose was not reported, administered on 04-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021 5 hours post vaccination, the patient experienced fever 100 F, backache, headache, stomach ache, and weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, backache, headache, and stomach ache, and had not recovered from weakness. This report was non-serious.; Sender's Comments: Fever 100 F, backache, headache, stomach ache, and weakness. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship. There are no other factors more likely to be associated with the event(s) than the drug.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Asthenia, Back pain, Body temperature, Headache
Clinical narrative: FEVER; BACKACHE; HEADACHE; STOMACH ACHE; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020) dose was not reported, administered on 04-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021 5 hours post vaccination, the patient experienced fever 100 F, backache, headache, stomach ache, and weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, backache, headache, and stomach ache, and had not recovered from weakness. This report was non-serious.; Sender's Comments: Fever 100 F, backache, headache, stomach ache, and weakness. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship. There are no other factors more likely to be associated with the event(s) than the drug.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia
Clinical narrative: FEVER; BACKACHE; HEADACHE; STOMACH ACHE; WEAKNESS; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805020) dose was not reported, administered on 04-MAR-2021 to Left Arm for prophylactic vaccination. No concomitant medications were reported.  On 04-MAR-2021 5 hours post vaccination, the patient experienced fever 100 F, backache, headache, stomach ache, and weakness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from fever, backache, headache, and stomach ache, and had not recovered from weakness. This report was non-serious.; Sender's Comments: Fever 100 F, backache, headache, stomach ache, and weakness. This event(s) is considered related. The event(s) has a compatible/suggestive temporal relationship. There are no other factors more likely to be associated with the event(s) than the drug.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cerebrovascular accident, Computerised tomogram head abnormal, Dizziness, Laboratory test, Visual impairment
Clinical narrative: Customer called me today wanting a copy of her immunization records. She explained that she received the Janssen Covid19 IMZ on Saturday 4/10.  The next day on 4/11 day she began experiencing dizziness, blurred vision and headache on the left side. She went to family practice on 4/14. The clinic immediately sent her to the Emergency Department for a brain scan which showed she had a blood clot and was currently having a stroke. She was admitted to the hospital. She was discharged from the hospital on 4/17 on  clopidogrel and atorvastatin. The hospital reported the hospitalization as possibly related to Janssen IMZ. ,
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Brain scan abnormal, Cerebral thrombosis, Cerebrovascular accident, Dizziness, Headache
Clinical narrative: Customer called me today wanting a copy of her immunization records. She explained that she received the Janssen Covid19 IMZ on Saturday 4/10.  The next day on 4/11 day she began experiencing dizziness, blurred vision and headache on the left side. She went to family practice on 4/14. The clinic immediately sent her to the Emergency Department for a brain scan which showed she had a blood clot and was currently having a stroke. She was admitted to the hospital. She was discharged from the hospital on 4/17 on  clopidogrel and atorvastatin. The hospital reported the hospitalization as possibly related to Janssen IMZ. ,
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vision blurred
Clinical narrative: Customer called me today wanting a copy of her immunization records. She explained that she received the Janssen Covid19 IMZ on Saturday 4/10.  The next day on 4/11 day she began experiencing dizziness, blurred vision and headache on the left side. She went to family practice on 4/14. The clinic immediately sent her to the Emergency Department for a brain scan which showed she had a blood clot and was currently having a stroke. She was admitted to the hospital. She was discharged from the hospital on 4/17 on  clopidogrel and atorvastatin. The hospital reported the hospitalization as possibly related to Janssen IMZ. ,
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure
Clinical narrative: He presented to the ER via ambulance after he had 3 witnessed seizures which included full loss of consciousness and rhythmic jerking lasting for an unknown duration.  En route apparently he was seizing and prehospital personnel gave him 5 mg IM versed as well as 5mg iv versed which did seem to abate the seizure.  He was apparently quite combative and has no prior history of seizures.  In the ER the patient was apparently having right sided eye deviation and was given 2mg of Ativan.  A stat CT of the head did not reveal any acute process.  Telemetry neurology was consulted.  During his work up the patient was found to have a urine toxicology positive for amphetamines as well as opiates.  Telemetry neurology recommended loading the patient with Keppra, initiating regular Keppra doses and indicated they believed the etiology of his seizures was polysubstance abuse.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Aggression, Computerised tomogram head, Dyskinesia, Gaze palsy, Loss of consciousness
Clinical narrative: He presented to the ER via ambulance after he had 3 witnessed seizures which included full loss of consciousness and rhythmic jerking lasting for an unknown duration.  En route apparently he was seizing and prehospital personnel gave him 5 mg IM versed as well as 5mg iv versed which did seem to abate the seizure.  He was apparently quite combative and has no prior history of seizures.  In the ER the patient was apparently having right sided eye deviation and was given 2mg of Ativan.  A stat CT of the head did not reveal any acute process.  Telemetry neurology was consulted.  During his work up the patient was found to have a urine toxicology positive for amphetamines as well as opiates.  Telemetry neurology recommended loading the patient with Keppra, initiating regular Keppra doses and indicated they believed the etiology of his seizures was polysubstance abuse.
Age: 58.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Seizure, Substance abuse, Toxicologic test
Clinical narrative: He presented to the ER via ambulance after he had 3 witnessed seizures which included full loss of consciousness and rhythmic jerking lasting for an unknown duration.  En route apparently he was seizing and prehospital personnel gave him 5 mg IM versed as well as 5mg iv versed which did seem to abate the seizure.  He was apparently quite combative and has no prior history of seizures.  In the ER the patient was apparently having right sided eye deviation and was given 2mg of Ativan.  A stat CT of the head did not reveal any acute process.  Telemetry neurology was consulted.  During his work up the patient was found to have a urine toxicology positive for amphetamines as well as opiates.  Telemetry neurology recommended loading the patient with Keppra, initiating regular Keppra doses and indicated they believed the etiology of his seizures was polysubstance abuse.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Panniculitis, Skin exfoliation
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Burning sensation, Contusion, Erythema, Skin discolouration, Skin exfoliation
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Wound drainage
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Burning sensation, Cellulitis, Rash
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Incorrect product administration duration, Injection site discolouration, Injection site pain, Injection site reaction, Injection site vesicles
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Pain, Thermal burn
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Blood test, Cellulitis, Drug hypersensitivity, Pain, Pain in extremity
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 52.0
Sex: F
Vaccine: COVID19, COVID19, COVID19, COVID19, COVID19
Symptoms: Panniculitis, Ultrasound scan, X-ray
Clinical narrative: pt with burning sensation and rash to left upper arm and cellulitis.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Tinnitus
Clinical narrative: COLD; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 to Left Deltoid for prophylactic vaccination.  No concomitant medications were reported. On 09-APR-2021, the subject experienced cold. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, had not recovered from headache, and the outcome of cold was not reported. This report was non-serious.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Chills, Headache, Nasopharyngitis
Clinical narrative: COLD; CHILLS; HEADACHE; This spontaneous report received from a patient concerned a 53 year old male. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 and expiry: UNKNOWN) dose was not reported, administered on 08-APR-2021 to Left Deltoid for prophylactic vaccination.  No concomitant medications were reported. On 09-APR-2021, the subject experienced cold. On 09-APR-2021, the subject experienced chills. On 09-APR-2021, the subject experienced headache. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, had not recovered from headache, and the outcome of cold was not reported. This report was non-serious.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Blood test, Chest discomfort, Dyspnoea, Electrocardiogram, Heart rate increased
Clinical narrative: Panic attack like episodes, sudden onset of shortness of breath, palpitation, dizziness, uneasiness. Lead to ED visit 2 times in last 4 days.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Hypoaesthesia, Panic attack, Throat tightness, Tremor, X-ray
Clinical narrative: Panic attack like episodes, sudden onset of shortness of breath, palpitation, dizziness, uneasiness. Lead to ED visit 2 times in last 4 days.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Chest X-ray normal, Dizziness, Dyspnoea, Electrocardiogram normal, Metabolic function test
Clinical narrative: Panic attack like episodes, sudden onset of shortness of breath, palpitation, dizziness, uneasiness. Lead to ED visit 2 times in last 4 days.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Palpitations, Panic attack, Troponin
Clinical narrative: Panic attack like episodes, sudden onset of shortness of breath, palpitation, dizziness, uneasiness. Lead to ED visit 2 times in last 4 days.
Age: 19.0
Sex: M
Vaccine: COVID19, COVID19, COVID19
Symptoms: Panic attack
Clinical narrative: Panic attack like episodes, sudden onset of shortness of breath, palpitation, dizziness, uneasiness. Lead to ED visit 2 times in last 4 days.